Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-30,300
Closed -$375K 463
2024
Q1
$375K Sell
30,300
-86
-0.3% -$1.03K 0.11% 162
2023
Q4
$331K Sell
30,386
-42,700
-58% -$380K 0.1% 186
2023
Q3
$585K Sell
73,086
-3,300
-4% -$27.6K 0.21% 122
2023
Q2
$733K Buy
76,386
+66,700
+689% +$692K 0.26% 100
2023
Q1
$116K Hold
9,686
0.05% 171
2022
Q4
$135K Buy
9,686
+1,900
+24% +$23K 0.06% 157
2022
Q3
$71K Buy
7,786
+86
+1% +$752 0.03% 188
2022
Q2
$61K Hold
7,700
0.03% 202
2022
Q1
$48K Hold
7,700
0.02% 248
2021
Q4
$70K Buy
+7,700
New +$85.4K 0.03% 220
2021
Q1
Sell
-990
Closed -$12K 435
2020
Q4
$12K Hold
990
﹤0.01% 328
2020
Q3
$16K Hold
990
﹤0.01% 337
2020
Q2
$22K Buy
+990
New +$16.6K ﹤0.01% 346

Other funds holding ZYXI

Denali Advisors's ZYXI Position: Q2 2024 in Review

Denali Advisors sold out of Zynex (ZYXI) in Q2 2024, closing a stake of 30,300 shares — an estimated $375K sold.

Denali Advisors first reported a position in ZYXI in Q2 2020 and held it in 13 quarters. The position peaked at $733K in Q2 2023. 110 funds tracked by Wall St. Rank hold ZYXI as of Q2 2024.

  • Denali Advisors reported no remaining Zynex position as of Q2 2024 after selling out during the quarter.
  • Denali Advisors sold 30,300 Zynex shares in Q2 2024, an estimated $375K.
  • Denali Advisors first reported a position in Zynex in Q2 2020 and held it in 13 quarters.
  • Denali Advisors's Zynex position peaked at $733K in Q2 2023.
  • 110 funds tracked by Wall St. Rank held Zynex as of Q2 2024.

Based on Denali Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.